|
Title:
|
CLOSED SESSION
CONFERENCE WITH LEGAL COUNSEL-POTENTIAL INITIATION OF LITIGATION/EXISTING LITIGATION pursuant to California Government Code Sections 54956.9(d)(4) and 54956.9(d)(1):
1. Multistate Government Entity Direct Settlement with Purdue Pharma L.P. & Sackler Family, In re National Prescription Opiate Litigation, United States District Court for the Northern District of Ohio, MDL No. 2804, Case No. 17-MD-2804 (class action); and United States Bankruptcy Court, Southern District of New York, Case No. 19-23649(SHL) (bankruptcy)
2. Nationwide Settlement with 8 Secondary Manufacturers, In re National Prescription Opiate Litigation, United States District Court for the Northern District of Ohio, MDL No. 2804, Case No. 17-MD-2804 (class action)
a. Alvogen, Inc.
b. Amneal Pharmaceuticals Inc.
c. Apotex Corp.
d. Hikma Pharmaceuticals USA, Inc.
e. Indivior Inc.
f. Mylan
g. Sun Pharmaceutical Industries, Inc.
h. Zydus Pharmaceuticals (USA) Inc.
|
TITLE
CLOSED SESSION
CONFERENCE WITH LEGAL COUNSEL-POTENTIAL INITIATION OF LITIGATION/EXISTING LITIGATION pursuant to California Government Code Sections 54956.9(d)(4) and 54956.9(d)(1):
1. Multistate Government Entity Direct Settlement with Purdue Pharma L.P. & Sackler Family, In re National Prescription Opiate Litigation, United States District Court for the Northern District of Ohio, MDL No. 2804, Case No. 17-MD-2804 (class action); and United States Bankruptcy Court, Southern District of New York, Case No. 19-23649(SHL) (bankruptcy)
2. Nationwide Settlement with 8 Secondary Manufacturers, In re National Prescription Opiate Litigation, United States District Court for the Northern District of Ohio, MDL No. 2804, Case No. 17-MD-2804 (class action)
a. Alvogen, Inc.
b. Amneal Pharmaceuticals Inc.
c. Apotex Corp.
d. Hikma Pharmaceuticals USA, Inc.
e. Indivior Inc.
f. Mylan
g. Sun Pharmaceutical Industries, Inc.
h. Zydus Pharmaceuticals (USA) Inc.
Label
Recommendation